Ir 17-08-2017 2

Diagno Labs
703-7th Floor, Raaj Chamber, Old Nagar Das Road,

Andheri
MUMBAI
RQ 91/ 8492 MAHARASTRA, INDIA
C012139-Portea-Mumbai
1st Floor Jai View apartment396/57 17th Road North AvenueSantacruz West
Mumbai, 400059
MAHARASHTRA, India
Tel : 9821544354
Email : shradha.raorane@porteamedical.com; sunita.pandey@porteamedical.com; pranali.shinde@porteamedical.com
NAME : DR PRIYA BHANUSHALI AGE : 32 Years SEX : Female

LAB REF NO.: 18271479 ACCESSION NO : 0007FH009839
COLLECTED ON : 16/08/2017 00:00 REGISTERED ON : 16/08/2017 18:47 REPORTED ON: 17/08/2017 00:46
Report Status : Final REFERRED BY : SELF
Tests Results Biological Reference Range Units
BIOCHEMISTRY
DEAL OF THE YEAR HEALTH PACKAGE-PORTEA

COMPLETE BLOOD COUNT (CBC) BLOOD
HEMOGLOBIN 12.4 12.0-15.0 g/dL

METHOD : PHOTOMETRIC
HEMATOCRIT 38.4 36.0-46.0 %

METHOD : AUTOMATED
RBC COUNT 5.03 High 3.80-4.80 10^6/uL

METHOD : IMPEDANCE
MCV 76.2 Low 83.0-101.0 fL

MCH 24.7 Low 27.0-32.0 pg
MCHC 32.4 31.5-34.5 g/dL
RDW-CV 17.1 High 11.6-14.0 %
METHOD : AUTOMATED
PLATELET COUNT 378 150-410 10^3/uL

TOTAL LEUCOCYTE COUNT 6.7 4.0 - 11.0 10^3/uL
METHOD : IMPEDANCE
DIFFERENTIAL LEUKOCYTE COUNT, BLOOD
NEUTROPHILS 49.0 40.0 - 80.0 %

LYMPHOCYTES 44.5 High 20.0 - 40.0 %
MONOCYTES 4.6 2.0 - 10.0 %
EOSINOPHILS 1.4 1.0 - 6.0 %
BASOPHILS 0.5 <2.0 %
ABSOLUTE NEUTROPHIL COUNT 3.28 2.00 - 7.00 10^3/uL
ABSOLUTE LYMPHOCYTE COUNT 2.98 1.00-3.00 10^3/uL
ABSOLUTE MONOCYTE COUNT 0.31 0.20-1.00 10^3/uL
ABSOLUTE EOSINOPHIL COUNT 0.09 0.02-0.50 10^3/uL
ABSOLUTE BASOPHIL COUNT 0.03 0.02-0.10 10^3/uL
METHOD : ABSORBANCE CYTOCHEMISTRY AND VOLUME
Comments
RBCS: PREDOMINANTLY NORMOCYTIC NORMOCHROMIC

WBCS: AS ABOVE
PLATELETS: ADEQUATE
This report belongs to Diagno Labs. Reproduction of Reports is not Permitted.

Page 1 Of 6
Diagno Labs
Andheri
MUMBAI
Mumbai, 400059
MAHARASHTRA, India
Tel : 9821544354

HBA1C (GLYCOSYLATED HEMOGLOBIN), BLOOD
HBA1C 5.9 4.3 - 6.4 %

METHOD : HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC).
MEAN PLASMA GLUCOSE 123 mg/dL
Interpretation(s)
GOOD CONTROL 6.4 - 7.0
FAIR CONTROL 7.0 - 8.0
ACTION SUGGESTED > 8.0
NOTE:
1. Glycosylated hemoglobin (HbA1c) test is done to assess compliance with therapeutic regimen in diabetic patients.
2. A three monthly monitoring is recommended in clinical management of diabetes.
3. It is not affected by daily glucose fluctuations, exercise and recent food intake.

Page 2 Of 6
Diagno Labs
Andheri
MUMBAI
Mumbai, 400059
MAHARASHTRA, India
Tel : 9821544354

4. The HbA1c is linearly related to the average blood sugar over the past 1-3 months (but is heavily weighted to the past 2-4 weeks).
5. The HbA1c is strongly associated with the risk of development and progression of microvascular and nerve complications
6. High HbA1c (>9.0-9.5%) is associated with very rapid progression of microvascular complications
7. Any condition that shorten RBC life span like acute blood loss, hemolytic anemia falsely lower HbA1c results.
8. HbA1c results from patients with HbSS, HbCC, HbSC and HbD must be interpreted with caution, given the pathological processes including anemia,
increased red cell turnover, and transfusion requirements that adversely impact HbA1c as a marker of long -term glycemic control.
9. Specimens from patients with polycythemia or post-splenectomy may exhibit increase in HbA1c values due to a somewhat longer life span of the red
cells.
10. The relationship between eAG (Mean Plasma Glucose) and HbA1c based on linear regression analysis :eAG(mg/dl)= (28.7*HbA1c)-46.7, (Diabetes
Care 2008;31:1-6).
GLUCOSE FASTING, PLASMA
GLUCOSE FASTING 94.0 70 - 110 mg/dL

METHOD : SPECTROPHOTOMETRY, HEXOKINASE
LIPID PROFILE, SERUM
CHOLESTEROL TOTAL 177.0 <200.0 DESIRABLE mg/dL

200.0 - 239.0 BORDERLINE
>/=240.0 HIGH
METHOD : SPECTROPHOTOMETRY, CHOD- POD METHOD
TRIGLYCERIDES 150.0 High <150 NORMAL mg/dL

150 – 199 BORDERLINE
200 - 499 HIGH
>/= 500 VERY HIGH
METHOD : SPECTROPHOTOMETRY, GPO- POD METHOD
CHOLESTEROL HDL, DIRECT 43.0 <40.0 LOW mg/dL

40.0 - 60.0 NORMAL
>/= 60.0 HIGH
METHOD : SPECTROPHOTOMETRY, DIRECT ENZYMATIC METHOD
CHOLESTEROL LDL, CALCULATED 104.0 High <100 OPTIMAL mg/dL

100 - 129 NEAR OR ABOVE OPTIMAL
130 - 159 BORDERLINE HIGH
160 - 189 HIGH
>/=190 VERY HIGH
CHOLESTEROL VLDL, CALCULATED 30.0 </= 30.0 mg/dL
CHOL / HDL RATIO 4.1 3.3 - 4.4 LOW RISK Ratio
4.5 - 7.0 AVERAGE RISK
7.1 - 11.0 MODERATE RISK
>11.0 HIGH RISK
METHOD : CALCULATED METHOD
BILIRUBIN, SERUM
BILIRUBIN TOTAL 0.28 Low 0.30 - 1.20 mg/dL

BILIRUBIN DIRECT 0.08 0.00 - 0.20 mg/dL
METHOD : SPECTROPHOTOMETRY, DIAZO METHOD
BILIRUBIN INDIRECT 0.20 0.20 - 1.00 mg /dL

ALANINE AMINOTRANSFERASE (ALT/ SGPT), SERUM
ALANINE AMINOTRANSFERASE (SGPT) 21.0 14 - 59 U/L

ASPARTATE AMINOTRANSFERASE (AST/SGOT), SERUM
ASPARTATE AMINOTRANSFERASE (SGOT) 19.0 15 - 37 U/L

METHOD : SPECTROPHOTOMETRY, UV WITH PYRIDOXAL-5-PHOSPHATE

Page 3 Of 6
Diagno Labs
Andheri
MUMBAI
Mumbai, 400059
MAHARASHTRA, India
Tel : 9821544354

ALKALINE PHOSPHATASE,SERUM
ALKALINE PHOSPHATASE 105.0 46.0 - 116.0 U/L

METHOD : SPECTROPHOTOMETRY, PNP AMP KINETIC
GAMMA GLUTAMYL TRANSFERASE(GGT), SERUM
GAMMA GLUTAMYL TRANSFERASE 27.0 5 - 55 U/L

PROTEIN TOTAL , SERUM
PROTEIN TOTAL 7.7 6.4 - 8.2 g/dL

METHOD : SPECTROPHOTOMETRY, BIURET
ALBUMIN,SERUM
ALBUMIN 3.5 3.4 - 5.0 g/dL

METHOD : BROMCRESOL PURPLE (BCP)
GLOBULIN, SERUM
GLOBULIN 4.2 High 2.0 - 4.10 g/dL

A:G RATIO
A:G RATIO 0.83 Low 1.0 - 2.1 Ratio

BLOOD UREA NITROGEN (BUN), SERUM
BLOOD UREA NITROGEN 6.00 Low 7.0 - 18.0 mg/dL

METHOD : SPECTROPHOTOMETRY, UREASE-GLDH
CREATININE, SERUM
CREATININE 0.9 0.60 - 1.00 mg/dL

METHOD : SPECTROPHOTOMETRY, JAFFE-KINETIC
URIC ACID, SERUM
URIC ACID 4.8 2.6 - 6.2 mg/dL

METHOD : SPECTROPHOTOMETRY, URICASE
CALCIUM, SERUM
CALCIUM 8.8 8.5 - 10.1 mg/dL

METHOD : SPECTROPHOTOMETRY, O-CRESOLPHTHALEIN COMPLEXONE (OCPC) REACTION
SODIUM, SERUM
SODIUM 142.0 136 - 145 mmol/L

METHOD : ISE, INDIRECT
POTASSIUM, SERUM
POTASSIUM 5.1 3.5 - 5.5 mmol/L

CHLORIDE, SERUM
CHLORIDE 102.0 98 - 111 mmol/L

METHOD : ISE, INDIRECT

Page 4 Of 6
Diagno Labs
Andheri
MUMBAI
Mumbai, 400059
MAHARASHTRA, India
Tel : 9821544354

IRON PROFILE
IRON 45.0 Low 50 - 170 µg/dL

TOTAL IRON BINDING CAPACITY 396.0 250 - 450 µg/dL
METHOD : SPECTROPHOTOMETRY, FERENE
% SATURATION 11.4 Low 13 - 45 %

Comments
KINDLY CORRELATE CLINICALLY.

MICROALBUMIN, RANDOM URINE
MICROALBUMIN, RANDOM URINE 21.1 <30.0 mg/L

METHOD : IMMUNOTURBIDIMETRY
CREATININE, RANDOM URINE
CREATININE, RANDOM URINE 181 UNDEFINED mg/dL

METHOD : SPECTROPHOTOMETRY, JAFFE-KINETIC
MICROALBUMIN/CREATININE RATIO
MICROALBUMIN/CREATININE RATIO 11.66 <30.0 NORMAL mg/g creat
30.0 - 299.0 MICROALBUMINURIA
>/=300.0 CLINICAL ALBUMINURIA

METHOD : CALCULATED METHOD
THYROID PROFILE ULTRA
TRI-IODO THYRONIN, (T3) 104.63 60.0 - 181.0 ng/dL

THYROXIN, (T4) 9.10 3.20 - 12.6 µg/dL
THYROID STIMULATING HORMONE (ULTRASENSITIVE) 4.514 0.55 - 4.78 µIU/mL
25-HYDROXY VITAMIN D, SERUM
25-HYDROXY VITAMIN D < 4.20 Low <20.0 DEFICIENCY ng/mL

20.0 - 30.0 INSUFFICIENCY
30.0 - 100.0 SUFFICIENCY
>100.0 TOXICITY
Interpretation(s)
Uses for Vitamin D assay:
• Diagnosis of Vitamin D deficiency
• Differential Diagnosis of causes of Rickets and Osteomalacia
• Monitoring Vitamin D replacement therapy
• Diagnosis of Hypervitaminosis D
LIMITATION:
Various methods are available for measuring circulating concentrations of 25-OH vitamin D. The studies report reasonable correlation between methods, but
with significant differences, the reasons for which are not well understood. Vitamin D values must be interpreted within the clinical context of each patient.

Page 5 Of 6
Diagno Labs
Andheri
MUMBAI
Mumbai, 400059
MAHARASHTRA, India
Tel : 9821544354

VITAMIN B12, SERUM
VITAMIN B12 546 211 - 911 pg/mL

METHOD : CHEMILUMINESCENCE (CLIA)
Interpretation(s)
Uses of Vitamin B12 assay :
• Investigation of macrocytic anaemia
• Work up of deficiencies seen in Megaloblastic Anemia
• Assistance in Diagnosis of CNS Disorders
• Evaluation of Alcoholism
• Evaluation of Malabsorption syndrome
Limitation:
• The evaluation of Macrocytic Anemia requires simultaneous measurement of both Vitamin B12 and folate levels.
• Patients taking B12 supplementation may have misleading results
ERYTHROCYTE SEDIMENTATION RATE, BLOOD
ESR 12 0 - 15 mm/hr
METHOD : WESTERGREN AUTOMATED
**End Of Report**
Dr. Kavita Dr. Rajeev S.Ramachandran

MBBS, MD (Pathology) MD (Pathology)

Page 6 Of 6

Ir 17-08-2017 2

Uploaded by

Copyright:

Available Formats

Ir 17-08-2017 2

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Ir 17-08-2017 2

Uploaded by

Copyright:

Available Formats

Diagno Labs

703-7th Floor, Raaj Chamber, Old Nagar Das Road,

NAME : DR PRIYA BHANUSHALI AGE : 32 Years SEX : Female

Tests Results Biological Reference Range Units

DEAL OF THE YEAR HEALTH PACKAGE-PORTEA

HEMOGLOBIN 12.4 12.0-15.0 g/dL

HEMATOCRIT 38.4 36.0-46.0 %

RBC COUNT 5.03 High 3.80-4.80 10^6/uL

MCV 76.2 Low 83.0-101.0 fL

PLATELET COUNT 378 150-410 10^3/uL

DIFFERENTIAL LEUKOCYTE COUNT, BLOOD

NEUTROPHILS 49.0 40.0 - 80.0 %

RBCS: PREDOMINANTLY NORMOCYTIC NORMOCHROMIC

This report belongs to Diagno Labs. Reproduction of Reports is not Permitted.

NAME : DR PRIYA BHANUSHALI AGE : 32 Years SEX : Female

Tests Results Biological Reference Range Units

HBA1C (GLYCOSYLATED HEMOGLOBIN), BLOOD

HBA1C 5.9 4.3 - 6.4 %

MEAN PLASMA GLUCOSE 123 mg/dL

This report belongs to Diagno Labs. Reproduction of Reports is not Permitted.

NAME : DR PRIYA BHANUSHALI AGE : 32 Years SEX : Female

Tests Results Biological Reference Range Units

GLUCOSE FASTING, PLASMA

GLUCOSE FASTING 94.0 70 - 110 mg/dL

LIPID PROFILE, SERUM

CHOLESTEROL TOTAL 177.0 &lt;200.0 DESIRABLE mg/dL

TRIGLYCERIDES 150.0 High &lt;150 NORMAL mg/dL

CHOLESTEROL HDL, DIRECT 43.0 &lt;40.0 LOW mg/dL

CHOLESTEROL LDL, CALCULATED 104.0 High &lt;100 OPTIMAL mg/dL

BILIRUBIN TOTAL 0.28 Low 0.30 - 1.20 mg/dL

BILIRUBIN INDIRECT 0.20 0.20 - 1.00 mg /dL

ALANINE AMINOTRANSFERASE (SGPT) 21.0 14 - 59 U/L

ASPARTATE AMINOTRANSFERASE (SGOT) 19.0 15 - 37 U/L

This report belongs to Diagno Labs. Reproduction of Reports is not Permitted.

NAME : DR PRIYA BHANUSHALI AGE : 32 Years SEX : Female

Tests Results Biological Reference Range Units

ALKALINE PHOSPHATASE 105.0 46.0 - 116.0 U/L

GAMMA GLUTAMYL TRANSFERASE(GGT), SERUM

GAMMA GLUTAMYL TRANSFERASE 27.0 5 - 55 U/L

PROTEIN TOTAL 7.7 6.4 - 8.2 g/dL

ALBUMIN 3.5 3.4 - 5.0 g/dL

GLOBULIN 4.2 High 2.0 - 4.10 g/dL

A:G RATIO 0.83 Low 1.0 - 2.1 Ratio

BLOOD UREA NITROGEN 6.00 Low 7.0 - 18.0 mg/dL

CREATININE 0.9 0.60 - 1.00 mg/dL

URIC ACID, SERUM

URIC ACID 4.8 2.6 - 6.2 mg/dL

CALCIUM 8.8 8.5 - 10.1 mg/dL

SODIUM 142.0 136 - 145 mmol/L

POTASSIUM 5.1 3.5 - 5.5 mmol/L

CHLORIDE 102.0 98 - 111 mmol/L

This report belongs to Diagno Labs. Reproduction of Reports is not Permitted.

NAME : DR PRIYA BHANUSHALI AGE : 32 Years SEX : Female

Tests Results Biological Reference Range Units

IRON 45.0 Low 50 - 170 µg/dL

% SATURATION 11.4 Low 13 - 45 %

KINDLY CORRELATE CLINICALLY.

MICROALBUMIN, RANDOM URINE 21.1 &lt;30.0 mg/L

CREATININE, RANDOM URINE

CHOLESTEROL TOTAL 177.0 <200.0 DESIRABLE mg/dL

TRIGLYCERIDES 150.0 High <150 NORMAL mg/dL

CHOLESTEROL HDL, DIRECT 43.0 <40.0 LOW mg/dL

CHOLESTEROL LDL, CALCULATED 104.0 High <100 OPTIMAL mg/dL

MICROALBUMIN, RANDOM URINE 21.1 <30.0 mg/L

MICROALBUMIN/CREATININE RATIO 11.66 <30.0 NORMAL mg/g creat

>/=300.0 CLINICAL ALBUMINURIA

25-HYDROXY VITAMIN D < 4.20 Low <20.0 DEFICIENCY ng/mL